611.9MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US1710774076
CUSIP
171077407
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
71.55
PEG Ratio
-
Book Value
0.60
Dividend Share
-
Dividend Yield
-
Earnings Share
0.11
Wall Street Target Price
8.82
EPS Estimate Current Year
0.12
EPS Estimate Next Year
0.20
EPS Estimate Current Quarter
0.018
EPS Estimate Next Quarter
0.02
Most Recent Quarter
-
Revenue TTM
99,597,000
Gross Profit TTM
61,586,000
EBITDA
8,540,000
Profit Margin
8.59%
Return On Assets TTM
7.84%
Return On Equity TTM
22.94%
Revenue Per Share TTM
1.312
Qtly Revenue Growth YOY
37.40%
Diluted Eps TTM
0.11
Qtly Earnings Growth YOY
0.00%
Trailing PE
71.55
Forward PE
63
Price Sales TTM
6.1437
Price Book MRQ
12.9039
Enterprise Value Revenue
5
Enterprise Value EBITDA
60
150.89
1.50%78.41
1.12%254.23
-3.85%510.81
-2.30%442.98
-1.75%542.28
-1.60%104.86
-1.40%93.37
-0.63%195.59
-0.61%308.70
-0.06%